Dexras2 activators include a diverse set of chemical compounds that enhance the functional activity of Dexras2 through various specific biochemical pathways. S-Nitrosoglutathione and NOC-18 are nitric oxide donors that promote the S-nitrosylation of Dexras2, a post-translational modification known to activate this protein. Farnesyl Acetate and Prenylamine, by influencing the prenylation and calcium levels respectively, ensure proper membrane localization and activation of Dexras2, which is critical for its signaling functions. Similarly, GTPγS, as a non-hydrolysable GTP analog, binds to Dexras2, stabilizing its active conformation. The beta-adrenoceptor agonist Isoprenaline, by increasing cAMP levels, indirectly supports the activation of Dexras2 through PKA-mediated phosphorylation pathways.
On the other hand, Ionomycin and Thapsigargin manipulate intracellular calcium concentrations, a key regulator of Dexras2 activity, through their ionophoric action and SERCA inhibition, respectively. The use of cAMP analogs such as 8-Bromo-cAMP and N6-Benzoyl-cAMP also results in PKA activation, which leads to phosphorylation events that enhance the activity of Dexras2. Forskolin, by elevating cAMP levels via adenylate cyclase activation, creates a cellular environment conducive to Dexras2 activation via PKA. Nitrendipine, though primarily a calcium channel blocker, indirectly contributes to the complex calcium-dependent regulation of Dexras2 activity within the cell. Collectively, these chemical compounds facilitate the activation of Dexras2, leveraging its role in intracellular signaling without the necessity of modifying gene expression or direct ligand binding.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
S-Nitrosoglutathione (GSNO) | 57564-91-7 | sc-200349 sc-200349B sc-200349A sc-200349C | 10 mg 25 mg 50 mg 100 mg | $87.00 $210.00 $346.00 $449.00 | 15 | |
S-Nitrosoglutathione directly donates NO groups, leading to S-nitrosylation of Dexras2, which is crucial for Dexras2 activation. | ||||||
Farnesyl acetate | 29548-30-9 | sc-235123 | 10 ml | $68.00 | ||
Farnesyl Acetate serves as a substrate for protein farnesyltransferase, leading to farnesylation and membrane association of Dexras2, enhancing its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol Hydrochloride, a beta-adrenoceptor agonist, increases cAMP levels, which can activate PKA and lead to phosphorylation that promotes Dexras2 activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, increasing intracellular calcium levels that can enhance Dexras2 activation through calmodulin-dependent pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog, which activates PKA and can lead to the phosphorylation and activation of Dexras2. | ||||||
Adenosine 3′,5′-cyclic Monophosphate, N6-Benzoyl-, Sodium Salt | 30275-80-0 | sc-300167 | 10 µmol | $324.00 | 1 | |
N6-Benzoyl-cAMP is another cAMP analog promoting PKA activation, which subsequently can enhance Dexras2 activity through phosphorylation. | ||||||
Nitrendipine | 39562-70-4 | sc-201466 sc-201466A sc-201466B | 50 mg 100 mg 500 mg | $109.00 $160.00 $458.00 | 6 | |
Nitrendipine, a calcium channel blocker, indirectly enhances Dexras2 activity by altering calcium dynamics within the cell. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP and activating PKA, which then can enhance the activation of Dexras2. | ||||||
NOC-18 | 146724-94-9 | sc-202247 sc-202247A sc-202247B sc-202247C | 10 mg 50 mg 100 mg 500 mg | $51.00 $184.00 $305.00 $1122.00 | 18 | |
NOC-18 acts as a nitric oxide donor, which can lead to the S-nitrosylation and activation of Dexras2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium and potential activation of Dexras2-related pathways. | ||||||